RxDoctor Payments Data

Saundra Homan

Family · Memphis, TNNPI 1780107219

Payments from drug & device makers

$5,187in general payments, 2019–2025

Across 167 payments — averaging $31.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ardelyx, Inc.$654
  • Lilly USA, LLC$535
  • Otsuka America Pharmaceutical, Inc.$531
  • Bayer$448
  • Novartis$448
  • AstraZeneca$423
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$5,03597%
  • Education$1523%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,187 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol58$49,328
JardianceEmpagliflozin41$37,720
Potassium Chloride46$797
Losartan Potassium54$313
Hydralazine Hcl33$309
Olmesartan Medoxomil16$294
Ciprofloxacin Hcl47$281
Calcitriol13$221
Allopurinol36$184
Lisinopril14$175
Furosemide46$162
Clonidine Hcl13$112
Amlodipine Besylate31$93
Atorvastatin Calcium27$79
Cephalexin17$75

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$423$49,32858 claims
Boehringer IngelheimJardiance$52$37,72041 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.

Other family in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →